Physician profile
Ellen Lide Mitchell
NPI 1952669186
$522.89
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.39 · 2020: $89.72 · 2021: $88.59 · 2022: $89.49 · 2023: $156 · 2024: $60.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $119.51 | 2020-2023 | |
| Qol Medical, LLC | $94.40 | 2019-2023 | Sucraid |
| Rhythm Pharmaceuticals, INC. | $75.97 | 2021-2022 | |
| Horizon Therapeutics Plc | $64.88 | 2023 | Tepezza |
| Genzyme Corporation | $59.04 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $26.31 | 2024 | Bylvay |
| Gilead Sciences, INC. | $25.74 | 2019 | |
| Pfizer INC. | $21.81 | 2020 | |
| Boston Scientific Corporation | $18.72 | 2020 | |
| Alcresta Therapeutics, INC. | $15.68 | 2024 | Relizorb |
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.